HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4%
HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4%
Approved
Approval ID
8967cd2b-c0a4-8df1-e053-2a95a90a3670
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 21, 2019
Manufacturers
FDA
Sincerus Florida, LLC
DUNS: 080105003
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4%
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72934-2098
Product Classification
G
Generic Name
HYALURONIC ACID SODIUM SALT 2% / MOMETASONE FUROATE 0.1% / NIACINAMIDE 4%
Product Specifications
Route of AdministrationTOPICAL
Effective DateMay 21, 2019
FDA Product Classification
INGREDIENTS (3)
HYALURONIC ACIDActive
Quantity: 2 g in 100 g
Code: S270N0TRQY
Classification: ACTIB
NIACINAMIDEActive
Quantity: 4 g in 100 g
Code: 25X51I8RD4
Classification: ACTIB
MOMETASONE FUROATEActive
Quantity: 0.1 g in 100 g
Code: 04201GDN4R
Classification: ACTIB